1354825-62-9 Usage
General Description
WEHI-345 (analog) is a chemical compound that acts as a potent and selective inhibitor of RIPK2, a protein kinase involved in the regulation of immune and inflammatory responses. By inhibiting RIPK2, WEHI-345 (analog) has the potential to modulate the immune system and reduce inflammation, making it a promising candidate for the treatment of autoimmune and inflammatory diseases. Research has shown that this compound exhibits high specificity and efficacy in inhibiting RIPK2, offering potential therapeutic benefits in a range of inflammatory conditions. Therefore, WEHI-345 (analog) represents a valuable tool for studying the role of RIPK2 in immune signaling and for developing novel treatments for immune-mediated diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 1354825-62-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,4,8,2 and 5 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1354825-62:
(9*1)+(8*3)+(7*5)+(6*4)+(5*8)+(4*2)+(3*5)+(2*6)+(1*2)=169
169 % 10 = 9
So 1354825-62-9 is a valid CAS Registry Number.
1354825-62-9Relevant articles and documents
PROTEIN KINASE INHIBITORS AND METHODS OF TREATMENT
-
, (2012/02/01)
The present invention relates to chemical compounds of formula (I) and methods for their use and preparation. In particular, the invention relates to substituted pyrazolo[3,4-d]pyrimidine based compounds which can be used in treating proliferative disorders, use of these compounds in methods of therapy and the manufacture of medicaments as well as compositions containing these compounds.
